BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38604128)

  • 21. Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes.
    Yalley A; Schill D; Hatta M; Johnson N; Cirillo LA
    J Biol Chem; 2016 Apr; 291(16):8848-61. PubMed ID: 26929406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
    Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
    Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-Wide Occupancy Profiling Reveals Critical Roles of FoxO1 in Regulating Extracellular Matrix and Circadian Rhythm Genes in Human Chondrocytes.
    Duffy T; Bekki H; Lotz MK
    Arthritis Rheumatol; 2020 Sep; 72(9):1514-1523. PubMed ID: 32281255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient chromatin accessibility mapping in situ by nucleosome-tethered tagmentation.
    Henikoff S; Henikoff JG; Kaya-Okur HS; Ahmad K
    Elife; 2020 Nov; 9():. PubMed ID: 33191916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1.
    Ujvari D; Jakson I; Babayeva S; Salamon D; Rethi B; Gidlöf S; Hirschberg AL
    PLoS One; 2017; 12(1):e0171004. PubMed ID: 28135285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brg1/PRMT5 nuclear complex epigenetically regulates FOXO1 in IPF mesenchymal progenitor cells.
    Jbeli AH; Yang L; Xia H; Gilbertsen AJ; Bitterman PB; Henke CA
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L344-L352. PubMed ID: 38252663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
    Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
    Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of putative FOXO1 genomic elements using an improved in vitro technique to isolate genomic regulatory sequences.
    Sidhu A; Miller PJ; Hollenbach AD
    Gene; 2010 Jun; 458(1-2):45-53. PubMed ID: 20338229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements.
    Vicente-García C; Villarejo-Balcells B; Irastorza-Azcárate I; Naranjo S; Acemel RD; Tena JJ; Rigby PWJ; Devos DP; Gómez-Skarmeta JL; Carvajal JJ
    Genome Biol; 2017 Jun; 18(1):106. PubMed ID: 28615069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
    Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
    Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components.
    Wu AL; Kim JH; Zhang C; Unterman TG; Chen J
    Endocrinology; 2008 Mar; 149(3):1407-14. PubMed ID: 18079193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative single-cell RNA and ATAC sequencing reveals that the FOXO1-PRDX2-TNF axis regulates tendinopathy.
    Guo J; Tang H; Huang P; Ye X; Tang C; Shu Z; Guo J; Kang X; Shi Y; Zhou B; Liang T; Tang K
    Front Immunol; 2023; 14():1092778. PubMed ID: 37223090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
    Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
    Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter.
    Tian YN; Chen HD; Tian CQ; Wang YQ; Miao ZH
    Cell Death Dis; 2020 Jan; 11(1):71. PubMed ID: 31992690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of FOXO1 and its role in disease progression.
    Xing YQ; Li A; Yang Y; Li XX; Zhang LN; Guo HC
    Life Sci; 2018 Jan; 193():124-131. PubMed ID: 29158051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leucine promotes differentiation of porcine myoblasts through the protein kinase B (Akt)/Forkhead box O1 signalling pathway.
    Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; Luo J; He J; Zheng P; Yu J
    Br J Nutr; 2018 Apr; 119(7):727-733. PubMed ID: 29569540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells.
    Kabrani E; Chu VT; Tasouri E; Sommermann T; Baßler K; Ulas T; Zenz T; Bullinger L; Schultze JL; Rajewsky K; Sander S
    Blood; 2018 Dec; 132(25):2670-2683. PubMed ID: 30333121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.
    Chapuy B; McKeown MR; Lin CY; Monti S; Roemer MG; Qi J; Rahl PB; Sun HH; Yeda KT; Doench JG; Reichert E; Kung AL; Rodig SJ; Young RA; Shipp MA; Bradner JE
    Cancer Cell; 2013 Dec; 24(6):777-90. PubMed ID: 24332044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.